Aging-US

Scope & Guideline

Pioneering Discoveries in Cellular Aging

Introduction

Delve into the academic richness of Aging-US with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1945-4589
PublisherIMPACT JOURNALS LLC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2009 to 2024
AbbreviationAGING-US / Aging-US
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127

Aims and Scopes

Aging-US is dedicated to publishing high-quality research articles that advance the understanding of aging and age-related diseases. The journal focuses on various aspects of aging, including molecular, cellular, and systemic mechanisms, and aims to bridge the gap between basic research and clinical applications.
  1. Molecular and Cellular Mechanisms of Aging:
    Research on the underlying biological processes that contribute to aging, including cellular senescence, oxidative stress, autophagy, and epigenetic modifications.
  2. Age-Related Diseases:
    Studies focusing on various diseases associated with aging, such as Alzheimer's disease, cardiovascular diseases, cancer, and metabolic disorders, highlighting their pathophysiology and potential therapeutic interventions.
  3. Impact of Lifestyle and Environmental Factors:
    Exploration of how diet, physical activity, and environmental exposures influence aging and the onset of age-related diseases.
  4. Innovative Therapeutic Approaches:
    Development and evaluation of new therapeutic strategies, including pharmacological agents, lifestyle interventions, and regenerative medicine techniques aimed at promoting healthy aging.
  5. Biomarkers of Aging:
    Identification and validation of biomarkers that can predict biological age, disease risk, and therapeutic responses in aging populations.
  6. Genetic and Epigenetic Influences:
    Investigation into the genetic and epigenetic factors that affect aging processes and contribute to the variability in aging among individuals.
In recent years, Aging-US has seen a rise in interest in several innovative and impactful themes within aging research. These emerging scopes reflect the evolving landscape of the field and highlight areas that are gaining traction among researchers.
  1. Longevity and Anti-Aging Interventions:
    Increased focus on lifestyle interventions, dietary restrictions, and pharmacological agents that target aging processes to extend lifespan and healthspan.
  2. Immunoaging and Inflammation:
    Growing interest in how aging affects immune function and the role of inflammation in age-related diseases, leading to research on immunotherapies and anti-inflammatory strategies.
  3. Epigenetics of Aging:
    Emerging studies on how epigenetic modifications influence aging processes, with implications for biomarkers and therapeutic targets.
  4. Microbiome and Aging:
    Research exploring the relationship between gut microbiota and aging, including how microbiome composition affects health outcomes in older adults.
  5. Artificial Intelligence in Aging Research:
    Utilization of AI and machine learning techniques to analyze aging data, predict outcomes, and personalize interventions in aging populations.
  6. Targeting Cellular Senescence:
    Increased emphasis on understanding and targeting cellular senescence as a therapeutic strategy to mitigate age-related decline and diseases.

Declining or Waning

While Aging-US continues to explore a broad range of topics related to aging, certain themes have shown a decline in prominence in recent years. These waning scopes may be reflective of shifting research interests or advancements in understanding that have rendered some areas less central.
  1. Traditional Herbal Remedies:
    Research focusing on traditional herbal treatments for aging and age-related diseases has decreased, as the field shifts towards more molecular and pharmacological approaches.
  2. Basic Descriptive Studies:
    There has been a decline in purely descriptive studies that do not incorporate mechanistic insights or translational aspects, reflecting a trend towards more hypothesis-driven research.
  3. Non-Specific Aging Models:
    The use of non-specific or generalized aging models in research is waning, with a preference for more targeted and disease-specific models that offer clearer insights into aging mechanisms.

Similar Journals

Skeletal Muscle

Connecting scholars and practitioners in the study of skeletal muscle.
Publisher: BMCISSN: 2044-5040Frequency: 1 issue/year

Skeletal Muscle is a prestigious open access journal published by BMC, dedicated to advancing the field of muscle biology and its associated disciplines. With an ISSN of 2044-5040, this journal has consistently been a beacon of knowledge and innovation since its inception in 2011. Based in the United Kingdom, Skeletal Muscle has established an impressive reputation as reflected in its category quartile rankings for 2023, achieving Q1 status in Cell Biology, Molecular Biology, and Orthopedics and Sports Medicine. This esteemed journal holds notable Scopus rankings, including a remarkable 12th place out of 321 in Orthopedics and Sports Medicine, positioning it in the 96th percentile. The journal is committed to disseminating high-quality, peer-reviewed research that fosters collaboration among scholars, healthcare professionals, and students alike. With a mission to explore the intricate biological mechanisms underlying skeletal muscle physiology and its impact on health and disease, Skeletal Muscle plays a vital role in shaping the future of research in this critical area, ensuring that cutting-edge findings are accessible to all.

Autophagy

Pioneering Research in Cellular Degradation and Renewal
Publisher: TAYLOR & FRANCIS INCISSN: 1554-8627Frequency: 12 issues/year

Autophagy is a premier peer-reviewed journal published by Taylor & Francis, Inc. in the United States, focusing on advances in the fields of Cell Biology and Molecular Biology. With an impressive impact factor reflected in its Q1 ranking in both categories, Autophagy stands as a vital resource for researchers and professionals dedicated to understanding the intricate mechanisms of cellular degradation and recycling. The journal has been a cornerstone of scientific communication since its inception in 2005, continuing to flourish through 2024, fostering collaboration and innovation in the study of autophagic processes. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and its commitment to publishing high-quality, impactful research. By bridging fundamental research with clinical applications, Autophagy plays a crucial role in advancing our understanding of various diseases, making it an essential tool for scholars and practitioners in the biomedical field.

EXPERIMENTAL GERONTOLOGY

Leading the Charge in Aging Research Since 1964
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0531-5565Frequency: 12 issues/year

EXPERIMENTAL GERONTOLOGY is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to the evolving field of aging research. With a rich history dating back to 1964 and continuing through 2024, this journal aims to advance the understanding of the biological processes underlying aging and develop interdisciplinary approaches to improve healthspan. ENCOMPASSING a broad scope, including *biochemistry*, *cell biology*, *endocrinology*, *genetics*, and *molecular biology*, it holds impressive rankings in the 2023 Scopus Ranks, featuring in Q1 and Q2 quartiles across multiple categories. This positions it as a vital resource for researchers and professionals focused on gerontology and related fields. As a subscription-based journal without open access, EXPERIMENTAL GERONTOLOGY ensures the dissemination of high-quality research through rigorous peer review, making it an essential publication for those aspiring to remain at the forefront of aging studies.

Epigenomes

Advancing Knowledge in Epigenomic Research
Publisher: MDPIISSN: Frequency: 4 issues/year

Epigenomes is a distinguished open access journal published by MDPI, dedicated to advancing the field of epigenetics and its interdisciplinary connections to biochemistry, genetics, and molecular biology. Since its inception in 2017, this journal has provided a transparent platform for researchers to share their findings, contributing to a deeper understanding of epigenetic mechanisms and their implications in health, toxicology, and mutagenesis. Ranked in the Q2 quartile across multiple categories, including biochemistry and genetics, Epigenomes is recognized for its scholarly contributions, reflected in its notable Scopus rankings. Readers benefit from a wealth of open access articles, fostering innovation and collaboration within the academic community. With its headquarters in Switzerland and an unwavering commitment to scientific rigor, Epigenomes is positioned as a vital resource for researchers, professionals, and students seeking to deepen their insights into the epigenomic landscape.

Aging Medicine

Transforming Aging Challenges into Opportunities
Publisher: WILEYISSN: Frequency: 4 issues/year

Aging Medicine, published by Wiley, is a pivotal open-access journal that has been at the forefront of research dedicated to the aging population since its inception in 2018. With a focus on both geriatric care and gerontology, the journal serves as a crucial resource for researchers, healthcare professionals, and students interested in understanding the complexities of aging and the related medical challenges. Although it holds a Q3 quartile ranking in the fields of Aging and Geriatrics and Gerontology according to the 2023 metrics, the journal continues to effectively disseminate valuable research and insights, helping to bridge gaps in knowledge and practice. With an E-ISSN of 2475-0360, it offers an open-access model that ensures broader accessibility to its published content, thus promoting collaboration and innovation across disciplines. As the journal converges towards 2024, it remains committed to evolving with the dynamics of aging research, making it a significant platform for the exchange of ideas and advancements in this essential field.

CELL CYCLE

Charting New Territories in Cell Cycle Understanding.
Publisher: TAYLOR & FRANCIS INCISSN: 1538-4101Frequency: 24 issues/year

CELL CYCLE, an esteemed journal published by Taylor & Francis Inc., stands at the forefront of biological research, focusing on the intricate mechanisms of cell proliferation, molecular biology, and developmental biology. With an ISSN of 1538-4101 and an E-ISSN of 1551-4005, this journal has established its influence in the field with a commendable impact factor reflecting its rigorous peer-review process and high-quality publications. Notably, in 2023, it achieved a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in both Cell Biology and Developmental Biology, marking its vital role in advancing scientific understanding and innovation. Operating within a converged framework from 2002 to 2024, CELL CYCLE caters to a diverse audience of researchers, professionals, and students eager to explore contemporary findings and emerging trends. The journal's objective is to disseminate groundbreaking research that enhances our understanding of cellular mechanisms, fostering collaboration and innovation. Although not an open-access journal, it remains a premier source for those engaged in cell cycle research, and its contributions have significant implications for fields such as healthcare, biotechnology, and genetics.

AGEING RESEARCH REVIEWS

Exploring the Frontiers of Age-Related Research
Publisher: ELSEVIER IRELAND LTDISSN: 1568-1637Frequency: 8 issues/year

AGEING RESEARCH REVIEWS, published by Elsevier Ireland Ltd, is a prestigious academic journal dedicated to advancing our understanding of the biological, psychological, and societal aspects of aging. With an ISSN of 1568-1637 and E-ISSN of 1872-9649, this journal has established itself as a leading resource in the fields of Aging, Biochemistry, Biotechnology, Molecular Biology, and Neurology, consistently ranked in the Q1 category across these disciplines as of 2023. For researchers, students, and professionals eager to explore cutting-edge findings and innovative methodologies, AGEING RESEARCH REVIEWS gathers comprehensive reviews that facilitate a deeper understanding of age-related processes. Its high impact factor and exceptional Scopus rankings—ranking #1 in Aging and #3 in Neurology—underscore its critical role in shaping contemporary aging research. This journal not only serves as a vital reference point but also fosters a collaborative space for the scientific community focused on improving health outcomes across the life span. Published continuously since 2002 and with a converging focus through 2024, AGEING RESEARCH REVIEWS remains committed to disseminating impactful knowledge that drives progress in our understanding of the aging process.

Advances in Gerontology

Elevating Research on the Aging Experience
Publisher: PLEIADES PUBLISHING INCISSN: 2079-0570Frequency: 4 issues/year

Advances in Gerontology is a pivotal academic journal dedicated to the field of gerontology, published by PLEIADES PUBLISHING INC. With its ISSN 2079-0570 and E-ISSN 2079-0589, this journal serves as an essential platform for researchers, healthcare professionals, and students focused on aging and related health issues. Although currently not an open-access journal, it aspires to enrich the scholarly community by disseminating high-quality research from 2011 through 2024. The journal is recognized in the lower quartile of its category, ranking Q4 in both Geriatrics and Gerontology, reflecting its commitment to addressing emerging topics in the aging population despite its lower visibility in the competitive landscape. As it continues to explore critical areas in gerontology, Advances in Gerontology invites contributions that advance knowledge, foster understanding, and inform practices within this essential field of study.

MECHANISMS OF AGEING AND DEVELOPMENT

Unraveling the Complexities of Life's Journey
Publisher: ELSEVIER IRELAND LTDISSN: 0047-6374Frequency: 8 issues/year

MECHANISMS OF AGEING AND DEVELOPMENT is a premier academic journal published by Elsevier Ireland Ltd, specializing in the fields of aging and developmental biology. With an impressive Q1 ranking in both categories as of 2023, this journal serves as a vital platform for researchers, professionals, and students seeking to advance their understanding of the complex biological processes that underlie aging and development. Since its inception in 1972, the journal has steadily contributed to the accumulation of valuable knowledge, maintaining a history of rigorous peer-reviewed articles that explore genetic, molecular, and cellular mechanisms impacting aging and development. Its high Scopus rankings—notably 5th in Aging and 8th in Developmental Biology—underscore its significance in the scientific community. While the journal follows a traditional publishing route without Open Access options, it remains an indispensable resource for those dedicated to the investigation of life’s aging processes and developmental phenomena. With publication projected through to 2024, the MECHANISMS OF AGEING AND DEVELOPMENT continues to shape the discourse within these critical research domains.

Cell Stress

Pioneering Insights into Cellular Resilience
Publisher: SHARED SCIENCE PUBLISHERS OGISSN: Frequency: 12 issues/year

Cell Stress is a prestigious, peer-reviewed open access journal dedicated to advancing research in the fields of biochemistry, genetics, molecular biology, cancer research, and physiology. Published by SHARED SCIENCE PUBLISHERS OG in Austria, this journal has rapidly established itself since its inception in 2017, achieving Q1 status in multiple categories, indicative of its high impact and quality. With an impressive Scopus ranking—holding a top percentile position in its respective fields—Cell Stress aims to foster interdisciplinary collaboration and disseminate cutting-edge findings that enhance our understanding of cellular stress mechanisms and their implications in health and disease. The journal's commitment to open access since its launch ensures that critical research is accessible to a global audience, thereby facilitating the exchange of knowledge among researchers, professionals, and students alike. Address your submissions or inquiries to AM BLUMENHAG 25-4, Graz 8010, Austria, and contribute to this dynamic platform that is shaping the future of molecular medicine.